The Myeloma Infoline and Ask The Nurse services are fully staffed and are here to answer your questions and concerns and be a listening ear.

You can also visit our dedicated COVID-19 Information Hub for the latest information.

Histone deacetylatse (HDAC) inhibitors

Histone deacetlyase inhibitors are a new type of myeloma treatment currently in clinical trial. Dr Charlotte Pawlyn explains how these inhibitors work and how they are likely to be given to patients.

Related Videos